Synthetic Biology for Accelerated Vaccine Discovery
Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.
mRNA vaccine
The quest for a respiratory syncytial virus vaccine is almost complete
After tragedy struck during a 1960s clinical trial, development of a vaccine for RSV ground to a halt. But as new RSV vaccine candidates enter late-stage clinical trials, a safe and effective vaccine is finally in sight.
